<DOC>
	<DOCNO>NCT01137435</DOCNO>
	<brief_summary>This safety surveillance study conduct accordance Korea Food Drug Administration ( KFDA ) Notification No . 2009-46 `` Basic standard reexamination new drug '' . The study objective ass within 30 day post-administration , safety ADACEL™ administer real clinical practice .</brief_summary>
	<brief_title>Post Marketing Surveillance ADACEL™ South Korea</brief_title>
	<detailed_description />
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Tetany</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<criteria>Inclusion Criteria : Subjects 11 64 year age ( indicate currently approve local product labeling ) , give single dose study vaccine , routine healthcare visit , active booster immunization prevention tetanus , diphtheria pertussis . Written inform consent obtain subject . For subject legal age consent , write informed consent must obtain parent legal guardian ( legally acceptable representative LAR ) subject . Exclusion Criteria :</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Adacel</keyword>
	<keyword>Diphtheria</keyword>
	<keyword>Tetanus</keyword>
	<keyword>Pertussis</keyword>
</DOC>